Bicycle Therapeutics plc - BCYC

About Gravity Analytica
Recent News
- 06.03.2025 - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 06.03.2025 - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 05.22.2025 - Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
- 05.22.2025 - Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
- 05.20.2025 - 2025 RBC Capital Markets Global Healthcare Conference
- 05.20.2025 - 2025 RBC Capital Markets Global Healthcare Conference
- 05.05.2025 - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 05.05.2025 - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 05.01.2025 - Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
- 05.01.2025 - Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
Recent Filings
- 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 05.01.2025 - 8-K Current report
- 05.01.2025 - EX-99.1 EX-99.1
- 05.01.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 04.29.2025 - 8-K Current report
- 04.29.2025 - EX-99.1 EX-99.1